Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Diagnostic concordance of neurasthenia spectrum disorders in Pune, India



Clinically significant fatigue or weakness is a common but understudied clinical problem in India. The applicability and relevance of Western clinical criteria in this setting are not studied. Alternative criteria sets used in different clinical contexts suggest a range of conditions constituting neurasthenia spectrum disorders (NSDs). We therefore aimed to determine frequency of patients with these complaints in four specialty outpatient clinics of an urban general hospital. We compared the concordance of four diagnostic criteria sets of fatigue disorders among the same patients.


Patients from the clinics of Psychiatry, Medicine, Dermatology, and Ayurved were screened for clinically significant fatigue or weakness and assessed for CFS, ICD-10 neurasthenia, DSM-IV draft criteria for neurasthenia, and CCMD-2 neurasthenia.


For 352 patients, sensitivity of CDC criteria for CFS (13.4%) was poorest. CFS was most frequent in the Medicine clinic. CCMD-2 criteria were the most frequently met (77.6%) with no significant difference across clinics. Two-way concordance of neurasthenia categories was no better than fair (≤0.4) and few patients (8.0%) met criteria for all four categories.


Four NSD criteria sets identified different clinical subgroups. CFS, considering fatigue and ignoring weakness, was least relevant for identifying NSD patients in these clinics. Poor concordance among the four diagnostic systems studied indicates the need for reviewing the nosology of these disorders. Focus on clinical significance alone is likely to avoid the discordant confusion arising from cross-cultural differences.

This is a preview of subscription content, log in to check access.


  1. 1.

    Afari N, Buchwald D (2003) Chronic fatigue syndrome: a review. Am J Psychiatry 160:221–236

  2. 2.

    Agashe M, Paralikar V, Weiss MG (1999) EMIC interview for study of disorders of fatigue and weakness. Maharashtra Institute of Mental Health and Swiss Tropical Inst

  3. 3.

    American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders (4th edn.) (DSM-IV). APA, Washington, DC

  4. 4.

    Bankier B, Aigner M, Bach M (2001) Clinical validity of ICD 10 neurasthenia. Psychopathology 34(3):134–139

  5. 5.

    Barsky AJ, Borus JF (1999) Functional somatic syndromes. Ann Intern Med 130:910–921

  6. 6.

    Bhatia MS, Malik SC (1991) Dhat syndrome – a useful diagnostic entity in Indian culture. Br J Psychiatry 159:691–695

  7. 7.

    Chang DF, Myers HF, Yeung A, et al. (2005) Shenjing Shuairuo and the DSM IV: diagnosis, distress and disability in a Chinese primary care setting. Transcult Psychiatry 42(2):204–218

  8. 8.

    Cheung FM (1989) The indigenization of neurasthenia in Hong Kong. Cult Med Psychiatry 13(2):227–241

  9. 9.

    Chinese Association of Neurology and Psychiatry (1989) Chinese classification of mental disorders, 2nd edn. Publishing House of Hunan University, Changsha, China

  10. 10.

    Chopra A, Lavin P, Patwardhan B, Chitre D (2000) Randomized double blind trial of an ayurvedic plant derived formulation for treatment of rheumatoid arthritis. J Rheumatol 27:1365–1372

  11. 11.

    Derogatis LR, Lipman RS, Covi L (1973) SCL-90: an outpatient psychiatric rating scale – preliminary report. Psychopharmacol Bull 9(1):13–28

  12. 12.

    First MB, Spitzer RL, Gibbon M, Williams JBW (1998) Structured clinical interview for DSM-IV Axis I disorders – patient edition (SCID-I/P, Version 2.0, 8/98 revision). Biometrics Research Department, New York State Psychiatric Institute, New York

  13. 13.

    Fleiss JL (1971) Measurement of nominal scale agreement among many raters. Psychol Bull 76(5):378–382

  14. 14.

    Fukuda K, Straus S, Hickie I, et al. (1994) International Chronic Fatigue Syndrome Study Group. The chronic fatigue syndrome: a comprehensive approach to its definition and study. Ann Intern Med 121(12):953–959

  15. 15.

    Holmes GP, Kaplan JE, Gantz NM (1988) Chronic fatigue syndrome: a working case definition. Ann Intern Med 108:387–389

  16. 16.

    Kirmayer LJ, Weiss M (1997) Cultural considerations for somatoform disorders. In: Widiger TA, Francis AJ, Pincus HA, Ross R, First MB, Davis W (eds) DSM-IV Sourcebook, vol 3. American Psychiatric Association, Washington DC, pp 933–941

  17. 17.

    Kleinman A (1980) Patients and their healers in the context of culture. University of California Press, Berkeley, CA

  18. 18.

    Maire B, Lioret S, Gartner A, et al. (2002) Nutritional transition and non-communicable diet-related chronic diseases in developing countries [Article in French] Sante. 12(1):45–55

  19. 19.

    Manton KG (1988) The global impact of non-communicable diseases: estimates and projections. World Health Stat Q 41(3–4):255–266

  20. 20.

    Paralikar V, Agashe M, Oke M, Dabholkar H, Abouihia A, Weiss MG (in press) Prevalence of clinically significant functional fatigue or weakness in specialty outpatient clinics of Pune, India. JIMA

  21. 21.

    Patel V, Kirkwood BR, Weiss H, Pednekar S, Fernandes J, Pereira B, Upadhye M, Mabey D (2005) Chronic fatigue in developing countries: population based survey of women in India. Br Med J 330:1190, doi:10.1136/bmj.38442.636181.E0

  22. 22.

    Prins JB, Van der Meer JWM, Bleijenberg G (2006) Chronic fatigue syndrome. Lancet 367:346–355

  23. 23.

    Ranjith G, Mohan R (2006) Dhat syndrome as a functional somatic syndrome: developing a sociosomatic model. Psychiatry 69(2):142–150

  24. 24.

    Ritsher JB (2005) Cultural factors and the international space station. Aviat Space Environ Med 76(6-II):B135–144

  25. 25.

    Skapinakis P, Lewis G, Mavreas V (2003) Cross-cultural differences in the epidemiology of unexplained fatigue syndromes in primary care. Br J Psychiatry 182:205–209

  26. 26.

    Smith RC, Gardiner JC, Lyles JS, et al. (2005) Exploration of DSM IV criteria in primary care patients with medically unexplained symptoms. Psychosom Med 67(1):123–129

  27. 27.

    Sumathipala A, Siribaddana SH, Bhugra D (2004) Culture-bound syndromes: the story of dhat syndrome. Br J Psychiatry 184:200–209

  28. 28.

    Weiss M (2001) Cultural epidemiology: an introduction and overview. Anthropol Med 8(1):5–29

  29. 29.

    Wessely S, Hotopf M, Sharpe M (1998) Epidemiology of fatigue. In: Chronic fatigue and its syndromes, Chapter 2. Oxford University Press, Oxford, p 19

  30. 30.

    Wessely S, White P (2004) There is only one functional somatic syndrome. Br J Psychiatry 185:95–96

  31. 31.

    Williams JBW (1988) The Structured Interview Guide for the Hamilton Anxiety and Depression Rating Scales (SIGH-AD). New York State Psychiatric Institute, New York

  32. 32.

    World Health Organization (1992a) The Tenth Revision of the International Classification of Diseases and Related Health Problems (ICD-10). WHO, Geneva

  33. 33.

    Young D (1989) Neurasthenia and related problems. Cult Med Psychiatry 13(2):131–138

  34. 34.

    Zhang MY (1989) The diagnosis and phenomenology of neurasthenia. A Shanghai study. Cult Med Psychiatry 13(2):147–161

Download references


This work is a part of the study, “Cultural Disorders Of Fatigue And Weakness In India”, headed by Dr Keh Ming Lin and funded by the US Dept of Public Health (US held Rupee Fund) grant No. N-439-645. We acknowledge the contributions of Dr D B Kadam for biomedical evaluation. We are indebted to the patients who participated in the study.

Author information

Correspondence to Vasudeo Paralikar.



Rights and permissions

Reprints and Permissions

About this article

Cite this article

Paralikar, V., Sarmukaddam, S., Agashe, M. et al. Diagnostic concordance of neurasthenia spectrum disorders in Pune, India. Soc Psychiat Epidemiol 42, 561–572 (2007).

Download citation


  • neurasthenia
  • fatigue disorders
  • culture-bound syndromes
  • diagnostic criteria
  • diagnostic sensitivities